ALFA Finder| Revenue growth | +27% YoY Q2; +15% H1 |
|---|---|
| Margins | Consolidated EBITDA 2.0% Q2; bio-chem 10.8%; sugar -2.6% |
| Demand visibility | Bio-chem offtake visible; capacity added as demand firms |
| Management confidence | Confident on bio-chem; sugar/ethanol under pressure |
Growth
Q2 revenue ₹549.2 Cr, +27% YoY; H1 ₹1,107.1 Cr, +15%. Bio-chem Q2 +39%, sugar/ethanol Q2 +21%.
Outlook
Bio-chem Q3 FY28E revenue target ₹240 Cr; ₹25 Cr debottlenecking capex; DME pilot by Q4 FY27.
Risks
Sugar/ethanol EBITDA loss ₹8.7 Cr Q2; feedstock stress, higher costs, lower ethanol tender allotments.
Last quarter's promises, checked
Delivered
- Bio-chem Q2 rev guided ₹190 Cr → beat (exact Q2 figure not in extract) (= BEAT)
Partly delivered
- ₹25 Cr debottlenecking capex guided to finish early FY28 → still planned, completion not yet shown (= PARTIAL)
Investor Presentation filed with BSE, NSE: GODAVARIB. Summary written with AI assistance from the document.
Godavari Biorefineries Ltd: key numbers
- Share price
- ₹226.08
- Market cap
- ₹1,157 Cr
- Revenue (annual)
- ₹1,988 Cr
- Net profit (annual)
- ₹3.53 Cr
- P/E (TTM)
- 43.5×Sector 28.2×
- Promoter holding
- 63.31%+0.00% QoQ
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Biorefineries Ltd
All →Godavari Biorefineries Earnings Call Transcript: Key Takeaways
Q2 revenue rose 27.5% to ₹549.2 Cr and net loss narrowed to ₹15.2 Cr. Chemicals drove gains; sugar-ethanol remains loss-making and seasonal.
Godavari Biorefineries Results Update
Q2 FY27 revenue rose 26.6% YoY to Rs.549.8 Crore, with EBITDA turning positive. Net loss narrowed to Rs.15.2 Crore from Rs.41.6 Crore a year earlier.
Godavari Biorefineries Q2 FY27 Results: Net Loss of ₹15.2 Cr, Loss Narrows
Godavari Biorefineries Ltd reported revenue from operations of ₹549.2 Cr (+27.5% YoY) and a net loss of ₹15.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹15.2 Cr
Godavari Biorefineries Board Meeting Date
Godavari Biorefineries has given prior intimation of a board meeting on 4 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October until 48 hours after results.
Godavari Biorefineries Other Announcement
Godavari Biorefineries Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This is a routine regulatory compliance filing.
Godavari Biorefineries Patent
Godavari Biorefineries Ltd has been granted a US patent for a compound targeting cancer treatment. This patent covers a novel class of cancer-inhibiting compounds.